Home Contact
Login   |  Tell a Friend
Financial Optimization through Technology Innovation
mutual fund
 Top Fund Managers
Latest Mutual Fund News Latest Mutual Fund News

Financial Advisor Sponsor:Dean L. Boebinger


 Bookmark this site!
Follow FundMojo on Twitter
Get Fund Information

Get Stock News

(Enter Stock Symbol)

Partner Sites

Annuities
Wall Street Journal
eHealthInsurance
Fund Mojo on Facebook
Fund Mojo help you discover the best fund managers, funds, and related information

Fund Intelligence | Best Managers | FBIOX Insights | FBIOX Score | FBIOX Performance | FBIOX Manager | FBIOX News | FBIOX Allocation | FBIOX Holdings Change

Mutual Fund Insights: Fidelity Select Biotechnology Fund (FBIOX)

In-depth Analysis of Fidelity Select Biotechnology Fund (FBIOX)

Mutual fund chart: Fidelity Select Biotechnology Fund (FBIOX)

3 months
6 months
1 year
3 year
5 year

See Fidelity Select Biotechnology Fund (FBIOX) performance details as of January 31, 2010

  

    Last Trade: $72.94 on 3/18/2010, Change: +0.03 (0.04%)

  

Fund Manager - Rajiv Kaul

Fund Manager Tenure: 4.4 years
Fundmojo Fund Grade: C (Score: 0.57)     (What does this score mean?)
Kaul is a portfolio manager with Fidelity Investments. Since joining Fidelity Investments in 1996, he has worked as a research analyst and portfolio manager. Kaul also manages another Fidelity fund. He is the recipient of the Kann Rasmusson Environment Award, the Dean's Summer Research Award and a Ford Undergraduate Fellowship.  Get more insights on Rajiv Kaul

  

What we like about Fidelity Select Biotechnology Fund (FBIOX) What we like about Fidelity Select Biotechnology Fund (FBIOX)

Data for Fidelity Select Biotechnology Fund (FBIOX) as of January 31, 2010

  • Fidelity Select Biotechnology Fund (FBIOX) management has been with Fidelity Select Biotechnology Fund for 4.4 years
  • Fidelity Select Biotechnology Fund (FBIOX) has good mid-term performance (3-year return 0.34% vs -0.24% Health category average)
  • Fidelity Select Biotechnology Fund (FBIOX) has good Long-term performance (5-year return 4.38% vs 4.22% Health category average)
  • Fidelity Select Biotechnology Fund (FBIOX) ratio of up-years vs down years is greater than 2
  • Fidelity Select Biotechnology Fund (FBIOX) has an annual stock turnover rate of 55.00% vs Health average of 152.72%. It is good that Fidelity Select Biotechnology management does not trade extensively for its return.
  • Fidelity Select Biotechnology Fund (FBIOX) has a lower management fee than its Health average: 0.89% vs 1.91%
  • Fidelity Select Biotechnology Fund (FBIOX) is a true no-load fund as it has no load and no 12b1 promotion, distributions, marketing expenses

  

What we are cautious about Fidelity Select Biotechnology Fund (FBIOX) What we are cautious about Fidelity Select Biotechnology Fund (FBIOX)

Data for Fidelity Select Biotechnology Fund (FBIOX) as of January 31, 2010

  • Fidelity Select Biotechnology Fund is a focused fund with 62.88% of the portfolio on top 10 securities. This tends to produce more volatility compared to a diversified fund. See fund top 10 holdings.
  • Fidelity Select Biotechnology Fund (FBIOX) has a less-than-ideal short-term performance (1-year return 12.77% vs 24.07% Health category average)
  • Fidelity Select Biotechnology Fund (FBIOX) has a Morningstar rating of 3 and below
  • Fidelity Select Biotechnology Fund (FBIOX) is less safe compared to its Health peers
  • Fidelity Select Biotechnology Fund (FBIOX) does not have a good risk adjusted return as its 3-year Alpha of 4.72 is worse than category average of 5.11, and its 3-year Sharpe ratio is 0.02
  • Fidelity Select Biotechnology Fund (FBIOX) is more volatile than its peers as it has a 3-year Standard Deviation of 20.61 that is higher than category average of 18.84
See Fidelity Select Biotechnology Fund (FBIOX) performance details as of January 31, 2010

  

  

Interested in other top mutual funds in similar Health category?

Below are some additional Health mutual funds generated out of our database

  

Fidelity Select Biotechnology Fund (FBIOX) Net Asset

Track net asset change of Fidelity Select Biotechnology fund (FBIOX)

DateNet Asset
01/2010$1.05B
11/2009$1.03B
10/2009$979.68M
More historic net asset information on Fidelity Select Biotechnology Fund (FBIOX)

  

Fidelity Select Biotechnology Fund (FBIOX) Portfolio Allocation

Track portfolio allocation change of Fidelity Select Biotechnology fund (FBIOX)

DateCashStockBondOther
10/20090%99.75%0%0.25%
09/20091.02%98.76%0%0.22%
08/20090.03%99.76%0%0.22%
Click here to see more historic asset allocation information on Fidelity Select Biotechnology Fund (FBIOX)

  

Most Recent Top 10 Holdings in Fidelity Select Biotechnology Fund (FBIOX)

Discover what Fidelity Select Biotechnology Fund (FBIOX) manager is buying

31-Oct-09
Amgen Inc. [20.94%]
Biogen Idec Inc [9.09%]
Alexion Pharmaceuticals, Inc. [6.36%]
Vertex Pharmaceuticals Incorpor [5.02%]
United Therapeutics Corporation [4.77%]
Gilead Sciences, Inc. [4.46%]
Genzyme Corporation [4.46%]
Cephalon, Inc. [3.86%]
Dendreon Corporation [3.7%]
Acorda Therapeutics, Inc. [3.61%]

30-Sep-09
Amgen Inc. [20.33%]
Biogen Idec Inc [9.44%]
Alexion Pharmaceuticals, Inc. [5.53%]
United Therapeutics Corporation [5%]
Vertex Pharmaceuticals Incorpor [4.91%]
Genzyme Corporation [4.65%]
Gilead Sciences, Inc. [4.22%]
Celgene Corporation [3.59%]
Cephalon, Inc. [3.57%]
Dendreon Corporation [3.55%]

31-Aug-09
Amgen Inc. [20.5%]
Biogen Idec Inc [9.54%]
Alexion Pharmaceuticals, Inc. [7.2%]
Genzyme Corporation [5.19%]
Vertex Pharmaceuticals Incorpor [5.16%]
United Therapeutics Corporation [5.04%]
Gilead Sciences, Inc. [4.64%]
Celgene Corporation [3.81%]
Cephalon, Inc. [3.55%]
Acorda Therapeutics, Inc. [3.26%]
Click here for Stock Holding Change Map in Fidelity Select Biotechnology Fund (FBIOX)

  

Related books and products to Fidelity Select Biotechnology Fund (FBIOX)

  

Latest News on Fidelity Select Biotechnology (FBIOX)

See what is happening with Fidelity Select Biotechnology Fund (FBIOX)

 

Books and Resources

 

 

See more information on Fidelity Select Biotechnology Fund (FBIOX)